240 related articles for article (PubMed ID: 1613816)
1. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia.
Nordberg A; Alafuzoff I; Winblad B
J Neurosci Res; 1992 Jan; 31(1):103-11. PubMed ID: 1613816
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies reveal the cellular localization and expression of cortical nicotinic and muscarinic cholinoceptors in human cerebral cortex.
Schröder H
Prog Histochem Cytochem; 1992; 26(1-4):266-70. PubMed ID: 1484965
[No Abstract] [Full Text] [Related]
3. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
[TBL] [Abstract][Full Text] [Related]
4. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.
Sugaya K; Giacobini E; Chiappinelli VA
J Neurosci Res; 1990 Nov; 27(3):349-59. PubMed ID: 2097379
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptors on human eccrine sweat gland in aging and Alzheimer's disease.
Ryer HI; Katz SE; Serby M
Biol Psychiatry; 1995 Feb; 37(4):259-64. PubMed ID: 7711163
[TBL] [Abstract][Full Text] [Related]
7. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain.
Perry EK; Smith CJ; Perry RH; Whitford C; Johnson M; Birdsall NJ
J Chem Neuroanat; 1989; 2(4):189-99. PubMed ID: 2597358
[TBL] [Abstract][Full Text] [Related]
8. Topographic distribution of choline acetyltransferase activity and muscarinic and nicotinic receptors in Parkinson brains.
Nordberg A; Nyberg P; Windblad B
Neurochem Pathol; 1985; 3(4):223-36. PubMed ID: 3831845
[TBL] [Abstract][Full Text] [Related]
9. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
Mufson EJ; Jaffar S; Levey AI
J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease.
Quirion R; Aubert I; Lapchak PA; Schaum RP; Teolis S; Gauthier S; Araujo DM
Trends Pharmacol Sci; 1989 Dec; Suppl():80-4. PubMed ID: 2694529
[TBL] [Abstract][Full Text] [Related]
11. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
Flynn DD; Weinstein DA; Mash DC
Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain.
Terry AV; Gearhart DA; Mahadik SP; Warsi S; Waller JL
Neuroscience; 2006 Jul; 140(4):1277-87. PubMed ID: 16626873
[TBL] [Abstract][Full Text] [Related]
13. Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system.
Rossner S; Schliebs R; Perez-Polo JR; Wiley RG; Bigl V
J Neurosci Res; 1995 Jan; 40(1):31-43. PubMed ID: 7714924
[TBL] [Abstract][Full Text] [Related]
14. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
Perry EK; Smith CJ; Court JA; Perry RH
J Neural Transm Park Dis Dement Sect; 1990; 2(3):149-58. PubMed ID: 2175197
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics.
Hellström-Lindahl E; Winblad B; Nordberg A
Brain Res; 1993 Aug; 620(1):42-8. PubMed ID: 8402197
[TBL] [Abstract][Full Text] [Related]
17. Brain muscarinic receptors in senile dementia.
Rinne JO; Laakso K; Lönnberg P; Mölsä P; Paljärvi L; Rinne JK; Säkö E; Rinne UK
Brain Res; 1985 Jun; 336(1):19-25. PubMed ID: 4005573
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
[TBL] [Abstract][Full Text] [Related]
19. Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains.
Nordberg A; Winblad B
Neurosci Lett; 1986 Dec; 72(1):115-9. PubMed ID: 3808458
[TBL] [Abstract][Full Text] [Related]
20. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia.
Sakurada T; Alufuzoff I; Winblad B; Nordberg A
Brain Res; 1990 Jun; 521(1-2):329-32. PubMed ID: 1698512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
